However, in T2DM patients, incretin accounts for just 20% of total insulin secretion due to decreased incretin secretion and dysfunctional receptor or postreceptor signaling, resulting in a decreased postprandial insulin and C-peptide secretion response, which contributes to hyperglycemia [3]. Here, INS is linked to type 2 diabetes mellitus.